Eupraxia Pharmaceuticals (EPRX.TO) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.59
-0.45
-0.31
-0.17

Details

Expected EPS
-0.181240776515916
Actual EPS
-0.17259333139731148
Surprise EPS
0.01
Surprise Percent
+4.77%

Description

⁨Eupraxia Pharmaceuticals⁩ (⁦EPRX.TO⁩) has reported earnings of ⁦-0.17259333139731148⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts